Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedAdded a publication citation for the CheckMate-032 study (J Clin Oncol, 2018). Deleted the erratum note for that publication (J Clin Oncol, 2019).SummaryDifference0.0%

- Check11 days agoChange DetectedNapoli, Italy, 80131 was changed to Naples, Italy, 80131 in the Locations section.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page's revision tag was updated to v3.5.0 and the previous v3.4.3 tag was removed.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. There are no visible changes to the study details or associated information.SummaryDifference0.0%

- Check32 days agoChange DetectedThe CheckMate-032 publication citation was added and then removed from the Publications section, resulting in no net change to the page content.SummaryDifference0.0%

- Check53 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' was added and an older funding/operating status notice was removed; these are administrative changes and do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.